Genmab A/S
Biotechnology & Medical Research
Company Summary
Genmab A/S is a Danish company that develops antibody therapies for the treatment of cancer and other disorders. Genmab A/S is based in Copenhagen, Denmark, and was formed in 1999.
Website : http://www.genmab.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
24.7
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
80
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Genmab is a leader among 43 companies in the biotechnology industry.
Temperature Rise :
1.7℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
